Format
Sort by
Items per page

Send to

Choose Destination

Links from Nucleotide

Items: 1 to 20 of 88

1.

Identification of Novel PROP1 and POU1F1 Mutations in Patients with Combined Pituitary Hormone Deficiency.

Birla S, Khadgawat R, Jyotsna VP, Jain V, Garg MK, Bhalla AS, Sharma A.

Horm Metab Res. 2016 Dec;48(12):822-827. Epub 2016 Oct 18.

PMID:
27756091
3.

All Hormone-Producing Cell Types of the Pituitary Intermediate and Anterior Lobes Derive From Prop1-Expressing Progenitors.

Davis SW, Keisler JL, Pérez-Millán MI, Schade V, Camper SA.

Endocrinology. 2016 Apr;157(4):1385-96. doi: 10.1210/en.2015-1862. Epub 2016 Jan 26.

4.

Two coexisting heterozygous frameshift mutations in PROP1 are responsible for a different phenotype of combined pituitary hormone deficiency.

Ziemnicka K, Budny B, Drobnik K, Baszko-Błaszyk D, Stajgis M, Katulska K, Waśko R, Wrotkowska E, Słomski R, Ruchała M.

J Appl Genet. 2016 Aug;57(3):373-81. doi: 10.1007/s13353-015-0328-z. Epub 2015 Nov 25.

5.

Novel Mutations in HESX1 and PROP1 Genes in Combined Pituitary Hormone Deficiency.

Avbelj Stefanija M, Kotnik P, Bratanič N, Žerjav Tanšek M, Bertok S, Bratina N, Battelino T, Trebušak Podkrajšek K.

Horm Res Paediatr. 2015;84(3):153-8. doi: 10.1159/000433468. Epub 2015 Jun 24.

PMID:
26111865
6.

Genesis of two most prevalent PROP1 gene variants causing combined pituitary hormone deficiency in 21 populations.

Dusatkova P, Pfäffle R, Brown MR, Akulevich N, Arnhold IJ, Kalina MA, Kot K, Krzisnik C, Lemos MC, Malikova J, Navardauskaite R, Obermannova B, Pribilincova Z, Sallai A, Stipancic G, Verkauskiene R, Cinek O, Blum WF, Parks JS, Austerlitz F, Lebl J.

Eur J Hum Genet. 2016 Mar;24(3):415-20. doi: 10.1038/ejhg.2015.126. Epub 2015 Jun 10.

7.

The c.301_302delAG PROP1 gene mutation in Romanian patients with multiple pituitary hormone deficiency.

Lazea C, Grigorescu-Sido P, Popp R, Legendre M, Amselem S, Al-Khzouz C, Bucerzan S, Creţ V, Crişan M, Brad C.

J Pediatr Endocrinol Metab. 2015 Sep;28(9-10):993-8. doi: 10.1515/jpem-2014-0289.

PMID:
25581745
8.

Molecular screening of a large cohort of Moroccan patients with congenital hypopituitarism.

Fritez N, Sobrier ML, Iraqi H, Vié-Luton MP, Netchine I, El Annas A, Pantel J, Collot N, Rose S, Piterboth W, Legendre M, Chraibi A, Amselem S, Kadiri A, Hilal L.

Clin Endocrinol (Oxf). 2015 Jun;82(6):876-84. doi: 10.1111/cen.12706. Epub 2015 Feb 6.

PMID:
25557026
9.

Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study.

Baş F, Uyguner ZO, Darendeliler F, Aycan Z, Çetinkaya E, Berberoğlu M, Şiklar Z, Öcal G, Darcan Ş, Gökşen D, Topaloğlu AK, Yüksel B, Özbek MN, Ercan O, Evliyaoğlu O, Çetinkaya S, Şen Y, Atabek E, Toksoy G, Aydin BK, Bundak R.

Endocrine. 2015 Jun;49(2):479-91. doi: 10.1007/s12020-014-0498-1. Epub 2014 Dec 11.

PMID:
25500790
10.

Circulating microRNA profiles and the identification of miR-593 and miR-511 which directly target the PROP1 gene in children with combined pituitary hormone deficiency.

Hu Y, Wang Q, Wang Z, Wang F, Guo X, Li G.

Int J Mol Med. 2015 Feb;35(2):358-66. doi: 10.3892/ijmm.2014.2016. Epub 2014 Nov 28.

11.

High prevalence of PROP1 defects in Lithuania: phenotypic findings in an ethnically homogenous cohort of patients with multiple pituitary hormone deficiency.

Navardauskaite R, Dusatkova P, Obermannova B, Pfaeffle RW, Blum WF, Adukauskiene D, Smetanina N, Cinek O, Verkauskiene R, Lebl J.

J Clin Endocrinol Metab. 2014 Jan;99(1):299-306. doi: 10.1210/jc.2013-3090. Epub 2013 Dec 20.

PMID:
24178788
12.

A PROP1-binding factor, AES cloned by yeast two-hybrid assay represses PROP1-induced Pit-1 gene expression.

Sugiyama Y, Ikeshita N, Shibahara H, Yamamoto D, Kawagishi M, Iguchi G, Iida K, Takahashi Y, Kaji H, Chihara K, Okimura Y.

Mol Cell Endocrinol. 2013 Aug 25;376(1-2):93-8. doi: 10.1016/j.mce.2013.05.022. Epub 2013 Jun 1.

PMID:
23732115
13.

Frequency of mutations in PROP-1 gene in Turkish children with combined pituitary hormone deficiency.

Kandemir N, Vurallı D, Taşkıran E, Gönç N, Özön A, Alikaşifoğlu A, Yılmaz E.

Turk J Pediatr. 2012 Nov-Dec;54(6):570-5.

PMID:
23692781
14.

Isolated central hypothyroidism in young siblings as a manifestation of PROP1 deficiency: clinical impact of whole exome sequencing.

Wassner AJ, Cohen LE, Hechter E, Dauber A.

Horm Res Paediatr. 2013;79(6):379-86. doi: 10.1159/000350013. Epub 2013 May 3.

15.

PROP-1 gene mutations in a 63-year-old woman presenting with osteoporosis and hyperlipidaemia.

Andrikoula M, Sertedaki A, Andrikoula S, Dacou-Voutetakis C, Tsatsoulis A.

Hormones (Athens). 2013 Jan-Mar;12(1):128-34.

16.
17.

Functional SNPs within the intron 1 of the PROP1 gene contribute to combined growth hormone deficiency (CPHD).

Godi M, Mellone S, Tiradani L, Marabese R, Bardelli C, Salerno M, Prodam F, Bellone S, Petri A, Momigliano-Richiardi P, Bona G, Giordano M.

J Clin Endocrinol Metab. 2012 Sep;97(9):E1791-7. doi: 10.1210/jc.2012-1527. Epub 2012 Jun 28.

PMID:
22745233
18.

PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without β-catenin mutations.

Cani CM, Matushita H, Carvalho LR, Soares IC, Brito LP, Almeida MQ, Mendonça BB.

Clinics (Sao Paulo). 2011;66(11):1849-54.

19.

Mutations and pituitary morphology in a series of 82 patients with PROP1 gene defects.

Obermannova B, Pfaeffle R, Zygmunt-Gorska A, Starzyk J, Verkauskiene R, Smetanina N, Bezlepkina O, Peterkova V, Frisch H, Cinek O, Child CJ, Blum WF, Lebl J.

Horm Res Paediatr. 2011;76(5):348-54. doi: 10.1159/000332693. Epub 2011 Oct 18.

PMID:
22024773
20.

CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas.

Campanini ML, Colli LM, Paixao BM, Cabral TP, Amaral FC, Machado HR, Neder LS, Saggioro F, Moreira AC, Antonini SR, de Castro M.

Horm Cancer. 2010 Aug;1(4):187-96. doi: 10.1007/s12672-010-0041-7.

PMID:
21761366

Supplemental Content

Support Center